肺癌中的内微生物群:TME调节和免疫疗法反应中的新兴作用
Xue Yang1, Liyuan Yin1, Zhuoying Tian1
1Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
International journal of molecular sciences
|January 10, 2026
概括
内微生物群通过调节瘤免疫微环境 (TIME) 显著影响肺癌免疫疗法. 了解这些微生物为改善治疗反应和克服耐药性提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 内微生物群越来越被认为是瘤免疫微环境 (TIME) 中的关键参与者.
- 这些微生物影响患者对癌症免疫疗法的反应,特别是在肺癌中.
- 它们的作用不仅仅是被动存在,而是积极调节抗瘤免疫力.
研究的目的:
- 审查内微生物群在肺癌免疫治疗反应中的作用.
- 阐明微生物影响瘤免疫微环境 (TIME) 的机制.
- 探索针对微生物群的策略,以克服免疫疗法耐药性.
主要方法:
- 使用PubMed和Web of Science进行了叙事文献综述.
- 从创立到2025年11月,搜索了英语文章.
- 对内微生物群,时间和免疫检查点抑制剂 (ICI) 治疗结果的综合证据.
主要成果:
- 内微生物,代谢物和囊泡显著影响时间和ICI疗效.
- 微生物特征显示出作为免疫治疗反应的预测生物标志物的潜力.
- 有证据表明,特定的微生物群组成与肺癌患者的治疗结果有关.
结论:
- 内微生物群是肺癌免疫治疗的关键调节器.
- 向瘤内微生物群是一个有希望的策略,以提高治疗疗效.
- 对微生物相互作用的进一步研究可以指导基于微生物群的精密疗法.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.0K
08:26Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
25.4K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
